scholarly journals Predictors of Long-term Maintenance of Normal Sinus Rhythm After Successful Electrical Cardioversion

2014 ◽  
Vol 37 (6) ◽  
pp. 381-385 ◽  
Author(s):  
Basil Abu-El-Haija ◽  
Michael C. Giudici
Keyword(s):  
Sinus Rhythm ◽  
Normal Sinus Rhythm ◽  
Electrical Cardioversion ◽  
Normal Sinus ◽  
Term Maintenance

Sotalol versus propafenone for long-term maintenance of normal sinus rhythm in patients with recurrent symptomatic atrial fibrillation

2004 ◽  
Vol 94 (12) ◽  
pp. 1563-1566 ◽  
Author(s):  
George E. Kochiadakis ◽  
Nikos E. Igoumenidis ◽  
Michail E. Hamilos ◽  
Panagiotis G. Tzerakis ◽  
Nikos C. Klapsinos ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Sinus Rhythm ◽  
Normal Sinus Rhythm ◽  
Normal Sinus ◽  
Term Maintenance

Long-term Maintenance of Normal Sinus Rhythm in Patients With Current Symptomatic Atrial Fibrillation

CHEST Journal ◽  
2004 ◽  
Vol 125 (2) ◽  
pp. 377-383 ◽  
Author(s):  
George E. Kochiadakis ◽  
Nikos E. Igoumenidis ◽  
Michail I. Hamilos ◽  
Panos G. Tzerakis ◽  
Nikos C. Klapsinos ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Sinus Rhythm ◽  
Normal Sinus Rhythm ◽  
Normal Sinus ◽  
Term Maintenance

scholarly journals Atrial Fibrillation Caused by Intractable Hiccups: A Unique Cause and Cure

2022 ◽  
Vol 2022 ◽  
pp. 1-4
Author(s):  
Joshua H. Arnold ◽  
Neil Brandon
Keyword(s):  
Myocardial Infarction ◽  
Atrial Fibrillation ◽  
Sinus Rhythm ◽  
Normal Sinus Rhythm ◽  
Electrical Cardioversion ◽  
Traditional Treatment ◽  
Cardiac Pathology ◽  
Normal Sinus ◽  
First Time ◽  
Intractable Hiccups

We present the case of a 61-year-old male who developed persistent hiccups concurrently with the onset of atrial fibrillation (AF). The hiccups were refractory to traditional treatment but resolved immediately upon electrical cardioversion (ECV) to normal sinus rhythm (NSR). The patient has remained in NSR and free of hiccups. The potential etiologies for hiccups are numerous and varied, and the management of persistent hiccups can be difficult. Cardiac associations including myocardial infarction and pericarditis have been described, while few cases of first-time onset of atrial fibrillation leading to hiccups have been documented. This case discusses a unique instance demonstrating a connection between hiccups and cardiac pathology and an overview of its management.

Amiodarone for the Maintenance of Sinus Rhythm in Patients with Atrial Fibrillation

1995 ◽  
Vol 29 (6) ◽  
pp. 596-602 ◽  
Author(s):  
Patricia A Howard
Keyword(s):  
Atrial Fibrillation ◽  
Sinus Rhythm ◽  
Randomized Trials ◽  
Normal Sinus Rhythm ◽  
Efficacy And Safety ◽  
Long Term Effects ◽  
Normal Sinus ◽  
Review Articles

Objective: To discuss the role of amiodarone for the maintenance of normal sinus rhythm in patients with atrial fibrillation (AF) and review the clinical trial data evaluating the efficacy and safety of amiodarone in patients with AF. Data Sources: A MEDLINE search was used to identify pertinent literature. Additional references were identified from the articles obtained in the search. Key search terms were atrial fibrillation, amiodarone, and sinus rhythm. Study Selection: All studies available at the time the article was prepared evaluating the efficacy and safety of amiodarone in AF were included. In addition, review articles discussing the role of amiodarone in AF were selected. Data Extraction: NO large, prospective, randomized trials have been performed. Data from 8 nonrandomized and 2 randomized trials are reported. Information derived from review articles is discussed. Data Synthesis: In patients with AF, maintenance of normal sinus rhythm is desirable to eliminate symptoms, improve functional capacity, and reduce the risk of thromboembolic complications. Class IA agents traditionally have been used; however, concerns about long-term effects on mortality have focused attention on other agents such as amiodarone. A number of nonrandomized, uncontrolled trials have found amiodarone to be effective for maintaining normal sinus rhythm in patients with AF that is refractory to conventional agents. Two randomized, nonblind trials have found amiodarone's efficacy to be equal to or superior to that of class IA drugs. The findings of these trials must be weighed, however, against the significant potential for toxicity and drug interactions associated with amiodarone. Cardiovascular toxicities, including proarrhythmic effects, appear to be relatively rare. In contrast, noncardiovascular effects are common and potentially serious. Conclusions: Although the preliminary data using amiodarone in AF are encouraging, many questions remain unanswered. Prospective, randomized trials are needed to evaluate the long-term efficacy and safety of amiodarone in patients with AF. Studies also are needed to determine the optimal dosing regimen. Until these data are available, each patient must be evaluated individually, taking into account the relative benefits and risks of therapy. Amiodarone may be particularly useful in patients with significant risks for proarrhythmia and those whose AF is refractory to traditional therapy.

scholarly journals “Wait and See” Approach to the Emergency Department Cardioversion of Acute Atrial Fibrillation

2011 ◽  
Vol 2011 ◽  
pp. 1-4 ◽  
Author(s):  
Brian Doyle ◽  
Mark Reeves
Keyword(s):  
Atrial Fibrillation ◽  
Emergency Department ◽  
Sinus Rhythm ◽  
Normal Sinus Rhythm ◽  
Routine Care ◽  
Spontaneous Resolution ◽  
Electrical Cardioversion ◽  
Normal Sinus ◽  
Degree Of Satisfaction ◽  
Wait And See

Objective. Acute atrial fibrillation often spontaneously resolves. This study aimed to investigate the outcomes and satisfaction of an evidence-based ED protocol employing a “wait and see” approach.Methods. A prospective observational cohort study of adult patients presenting to the Emergency Department with stable acute atrial fibrillation was performed. Patients were excluded if they were considered to be unstable, need hospitalization, or poor candidates for ED procedural sedation. Routine care was provided on the index visit, and suitable candidates were discharged and asked to return to the ED the following day for possible electrical cardioversion. Outcome measures included spontaneous reversion to sinus rhythm, success of cardioversion, length of stay, adverse event and return visits for AF within 30 days, and patient satisfaction.Results. Thirty five patient encounters were analysed over a 21-month period. Twenty two of the 35 patients (63%) had spontaneous resolution of atrial fibrillation upon presentation for potential cardioversion. All of the remaining patients underwent successful cardioversion to normal sinus rhythm without significant adverse events recorded. No patients required hospitalization. Three patients (9%) returned to the ED within 30 days for recurrence of atrial fibrillation. All patients were reported to be “very satisfied” with this approach.Conclusion. A “wait and see” approach to the ED electrical cardioversion of atrial fibrillation showed that almost two-thirds of patients had spontaneous resolution without requiring cardioversion or observation in the ED or hospital. All patients were successfully reverted to normal sinus rhythm and had a high degree of satisfaction.

Conversion to Normal Sinus Rhythm by Propofol during Electrical Cardioversion in Atrial Flutter and Idiopathic Ventricular Tarchycardia

2002 ◽  
Vol 42 (2) ◽  
pp. 245
Author(s):  
Tae Jung Kim ◽  
Jeong Uk Han ◽  
Chong kweon Chung ◽  
Yi Hoe Heo ◽  
Sung Keum Lee ◽  
...  
Keyword(s):  
Sinus Rhythm ◽  
Atrial Flutter ◽  
Normal Sinus Rhythm ◽  
Electrical Cardioversion ◽  
Normal Sinus

scholarly journals Do all patients with atrial fibrillation need long-term anticoagulation?

2017 ◽  
Vol 7 (3) ◽  
Author(s):  
Munish Sharma ◽  
Rohit Masih ◽  
Daniel A.N. Mascarenhas
Keyword(s):  
Atrial Fibrillation ◽  
Sinus Rhythm ◽  
Normal Sinus Rhythm ◽  
Oral Anticoagulants ◽  
Heart Association ◽  
The United States ◽  
Ventricular Rate ◽  
Normal Sinus ◽  
Systemic Embolization

Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide with an estimated number of 2.7-6.1 million cases in the United States (US) alone. The incidence of AF is expected to increase 2.5 fold over the next 50 years in the US. The management of AF is complex and includes mainly three aspects; restoration of sinus rhythm, control of ventricular rate and prevention of systemic thromboembolism. AF as a cause of systemic embolization has been well known for many years, and majority of patients are on oral anticoagulants (OACs) to prevent this. Many times, a patient may not be in AF chronically, nor is the AF burden (the amount of time patient is in AF out of the total monitored time) calculated. We present three cases of new onset transient AF triggered by temporary stressors. We were able to restore normal sinus rhythm (NSR) with chemical cardioversion. As per 2014 American College of Cardiology (ACC)/American Heart Association (AHA) recommendations, we started all three patients on OACs based on CHA<sub>2</sub>DS<sub>2</sub>VASc score <span style="text-decoration: underline;">&gt;</span>2. However, the patients refused long term OACs after restoration of NSR and correction of the temporary enticing stressors. In any case, the decision to start OACs would have had its own risks. Here we describe how antiarrhythmic drugs were used to maintain NSR, all while they were continuously monitored to determine the need to continue OACs.

Sign in / Sign up

Export Citation Format

Share Document